Science News

RAHWAY, N.J.--(BUSINESS WIRE)--Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for Merck’s WINREVAIR in Adults With CpcPH-HFpEF...

SOUTH SAN FRANCISCO, Calif., & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan announced results from KARDINAL, a Phase 2 clinical trial evaluating the effects of tonlamarsen in patients with uncontrolled hypertension....

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm....

PRINCETON, N.J.--(BUSINESS WIRE)--Open Label Outpatient Switch Study Demonstrates Symptom Stability During Transition from Oral Atypical Antipsychotics to Cobenfy....

LOS ANGELES--(BUSINESS WIRE)--Los Angeles is charting a bold new course into the Deep Blue Decade. Los Angeles Harbor College, in partnership with the California Community Colleges Chancellor’s Office, AltaSea at the Port of Los Angeles, and a consortium of 14 colleges, announced the next wave of Blue Economy workforce development through the 3rd Annual Blue Economy & Climate Action Pathways (BECAP) Summit — a landmark collaboration shaping the workforce ecosystems of tomorrow. Hosted at Lo...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today provided a corporate update following the filing of its 10-K on Friday, March 27, 2026, which reported financial results for the fourth quarter and year ended December 31, 2025. CEO Commentary: “The year 2025 was a year of important scientific progress for En...

SAN ANTONIO, Texas--(BUSINESS WIRE)--IVF Academy USA, the rapidly growing training institution for embryologists and fertility laboratory professionals, today announced the launch of its new OBGYN Clinic-Ready Fertility Services Accelerator Program, a 30-hour hybrid training designed to help board-certified OBGYNs integrate fertility services directly into their practices. Under the leadership of Founder Dr. Anthony Anderson, D.H.Sc., ELD (ABB), a nationally recognized embryology laboratory dir...

BELLINGHAM, Wash.--(BUSINESS WIRE)--The AR Alliance, a division of SPIE that is focused on augmented reality (AR), proudly announces the addition of Ainstec, ams-Osram, Fraunhofer ISIT, Hong Kong Highpower International Co., Infineon, Kyocera Corporation, Morphotonics, Moveon Technologies, Murata Manufacturing Co., Seagate, Sunny Optical Technology, and Ushio to its membership. SPIE is the international society for optics and photonics. Members of the AR Alliance reflect the global diversity an...

MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today announced new long-term results from EFFISAYIL® ON, an ongoing five-year open-label extension study of the pivotal EFFISAYIL 1 trial and the EFFISAYIL 2 trial, evaluating the efficacy, safety and tolerability of SPEVIGO® (spesolimab-sbzo) injection in patients with generalized pustular psoriasis (GPP). The findings are being shared at the 2026 American Academy of Dermatology (AAD) Annual Meeting.1,2 GP...